Curlee, M.S.; Toledo-Tamula, M.A.; Baker, M.; Wikstrom, D.; Harrison, C.; Rhodes, A.; Fagan, M.; Tibery, C.; Wolters, P.L.; Widemann, B.C.;
et al. A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib. Cancers 2025, 17, 295.
https://doi.org/10.3390/cancers17020295
AMA Style
Curlee MS, Toledo-Tamula MA, Baker M, Wikstrom D, Harrison C, Rhodes A, Fagan M, Tibery C, Wolters PL, Widemann BC,
et al. A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib. Cancers. 2025; 17(2):295.
https://doi.org/10.3390/cancers17020295
Chicago/Turabian Style
Curlee, Millicent S., Mary Anne Toledo-Tamula, Melissa Baker, Daniel Wikstrom, Cynthia Harrison, Amanda Rhodes, Margaret Fagan, Cecilia Tibery, Pamela L. Wolters, Brigitte C. Widemann,
and et al. 2025. "A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib" Cancers 17, no. 2: 295.
https://doi.org/10.3390/cancers17020295
APA Style
Curlee, M. S., Toledo-Tamula, M. A., Baker, M., Wikstrom, D., Harrison, C., Rhodes, A., Fagan, M., Tibery, C., Wolters, P. L., Widemann, B. C., Gross, A. M., & Martin, S.
(2025). A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib. Cancers, 17(2), 295.
https://doi.org/10.3390/cancers17020295
